http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100535003-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d98c39b278e59d31d5cdb5a8671536c0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| filingDate | 2004-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db8fb9fbe87bf25383dfdb6967d97d88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88661cdd96f9d03df40156bae8a983b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5de20d11c0c3b247230e9178a073f112 |
| publicationDate | 2009-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-100535003-C |
| titleOfInvention | Analog of Exendin 4 |
| abstract | The present invention relates to polypeptides as exendin4 analogs. The polypeptides with the effect of lowering blood sugar can be used for treating type II diabetes. The present invention also provides a medical composition containing the polypeptides and a method for producing the polypeptides by a chemical synthesis process and a recombinant DNA production process. |
| priorityDate | 2004-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 173.